JP2020519904A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519904A5 JP2020519904A5 JP2020511871A JP2020511871A JP2020519904A5 JP 2020519904 A5 JP2020519904 A5 JP 2020519904A5 JP 2020511871 A JP2020511871 A JP 2020511871A JP 2020511871 A JP2020511871 A JP 2020511871A JP 2020519904 A5 JP2020519904 A5 JP 2020519904A5
- Authority
- JP
- Japan
- Prior art keywords
- timp
- igfbp7
- replacement therapy
- concentration
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023052930A JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762502728P | 2017-05-07 | 2017-05-07 | |
| US62/502,728 | 2017-05-07 | ||
| PCT/US2018/031425 WO2018208684A1 (en) | 2017-05-07 | 2018-05-07 | Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023052930A Division JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020519904A JP2020519904A (ja) | 2020-07-02 |
| JP2020519904A5 true JP2020519904A5 (enExample) | 2021-08-19 |
Family
ID=64105628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511871A Pending JP2020519904A (ja) | 2017-05-07 | 2018-05-07 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
| JP2023052930A Pending JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023052930A Pending JP2023082094A (ja) | 2017-05-07 | 2023-03-29 | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210025875A1 (enExample) |
| EP (1) | EP3621987A4 (enExample) |
| JP (2) | JP2020519904A (enExample) |
| CN (1) | CN110753700A (enExample) |
| WO (1) | WO2018208684A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010048346A1 (en) | 2008-10-21 | 2010-04-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| MX342967B (es) | 2009-12-20 | 2016-10-19 | Astute Medical Inc | Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal. |
| NZ605698A (en) | 2010-06-23 | 2015-03-27 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP3540440B1 (en) | 2011-12-08 | 2022-09-28 | Astute Medical, Inc. | Methods and uses for evaluating renal injury and renal status |
| JP6681195B2 (ja) | 2013-01-17 | 2020-04-15 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物 |
| CN110007084B (zh) | 2013-12-03 | 2022-11-18 | 阿斯图特医药公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
| AU2017277305A1 (en) | 2016-06-06 | 2018-12-20 | Astute Medical, Inc. | Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 |
| CN110431422A (zh) | 2017-02-06 | 2019-11-08 | 机敏医药股份有限公司 | 用于肾损伤和肾衰竭的诊断和预后的方法和组合物 |
| WO2018187453A1 (en) | 2017-04-05 | 2018-10-11 | Astute Medical, Inc. | Assays for timp2 having improved performance in biological samples |
| JP2024516679A (ja) * | 2021-04-30 | 2024-04-16 | エフ． ホフマン－ラ ロシュ アーゲー | 敗血症の早期検出用のｉｇｆｂｐ７マーカーパネル |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| CA2072758A1 (en) | 1990-09-14 | 1992-03-15 | Kenneth Francis Buechler | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| AU1772992A (en) | 1991-04-10 | 1992-11-17 | Biosite Diagnostics Incorporated | Crosstalk inhibitors and their uses |
| EP0579767B1 (en) | 1991-04-11 | 2000-08-23 | Biosite Diagnostics Inc. | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| MX342967B (es) * | 2009-12-20 | 2016-10-19 | Astute Medical Inc | Metodos y composiciones para la diagnosis y prognosis de lesion renal y falla renal. |
| CN105051542A (zh) | 2012-10-31 | 2015-11-11 | 阿斯图德医疗有限公司 | 定量的侧向流测定法 |
| WO2016164854A1 (en) * | 2015-04-09 | 2016-10-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| KR102083104B1 (ko) * | 2015-10-08 | 2020-02-28 | 에프. 호프만-라 로슈 아게 | 수술 전 측정시 ａｋｉ 의 위험 예측을 위한 ｉｇｆｂｐ７ |
-
2018
- 2018-05-07 WO PCT/US2018/031425 patent/WO2018208684A1/en not_active Ceased
- 2018-05-07 US US16/611,456 patent/US20210025875A1/en not_active Abandoned
- 2018-05-07 EP EP18797960.4A patent/EP3621987A4/en active Pending
- 2018-05-07 CN CN201880040347.5A patent/CN110753700A/zh active Pending
- 2018-05-07 JP JP2020511871A patent/JP2020519904A/ja active Pending
-
2023
- 2023-03-29 JP JP2023052930A patent/JP2023082094A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008501979A5 (enExample) | ||
| JP2021513077A5 (enExample) | ||
| JP2023082094A (ja) | 腎代替療法の管理におけるインスリン様増殖因子結合タンパク質７および組織メタロプロテアーゼ阻害物質２の使用 | |
| JP2010529468A5 (enExample) | ||
| RU2015144699A (ru) | Адреномедуллин для направленной терапии по снижению кровяного давления | |
| JP2021502573A5 (enExample) | ||
| JP2019523889A5 (enExample) | ||
| Cho et al. | Effect of contrast-induced nephropathy on cardiac outcomes after use of nonionic isosmolar contrast media during coronary procedure | |
| JP2012530253A5 (enExample) | ||
| JP2010500535A5 (enExample) | ||
| ATE336003T1 (de) | Verfahren zur sepsisdiagnose durch bestimmung von anti-asialo-gangliosid-antikörpern | |
| Heuzeroth et al. | Exploratory testing of functional blood oxygenation level dependent-MRI to image the renoprotective effect of Remote Ischaemic PreConditioning during partial nephrectomy | |
| Lone et al. | The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy | |
| Vrtovsnik et al. | Induction of chronic kidney failure in a long-term peritoneal exposure model in the rat: effects on functional and structural peritoneal alterations | |
| Zhao et al. | Benefits of early treatment for patients with hepatic myelopathy secondary to TIPS: a retrospective study in Northern China | |
| JPH11506205A (ja) | 炎症プロセスの病因を決定するための診断方法 | |
| RU2016102202A (ru) | Биологический маркер опухоли | |
| Afsar et al. | The relationship between aortic knob width and various demographic, clinical, and laboratory parameters in stable hemodialysis patients | |
| Winkes et al. | Chronic exertional compartment syndrome of the deep posterior lower leg | |
| JP6727660B2 (ja) | 糖尿病性腎症の判定マーカー | |
| Holmar et al. | New optical method for estimation of protein bound uremic toxins elimination | |
| US20200340913A1 (en) | Method for spectral study of a biological fluid | |
| ATE359519T1 (de) | Diagnostisches verfahren für chronische obstruktive lungen krankheit | |
| Kengne | ADVANCE and risk evaluation in diabetes | |
| Castro et al. | 76: Urinary Tract Infection in HTLV-1 Positive Individuals |